SSRI-induced parkinsonism may be an early sign of future Parkinson's disease.
Gönül
A S
AS
Aksu
M
M
D000367:Age Factors; D000368:Aged; D015897:Comorbidity; D003866:Depressive Disorder / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D016666:Fluvoxamine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D010300:Parkinson Disease / Q000453:epidemiology*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000453:epidemiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D016666:Fluvoxamine; D017367:Selective Serotonin Reuptake Inhibitors